Therapeutic abstention in the treatment of depression in first-episode psychosis

Therapeutic abstention in the treatment of depression in first-episode psychosis

J Psychiatry Neurosci 2020;45(6):441-442 | PDF

Priyadharshini Sabesan, MD, MRCPsych; Lena Palaniyappan, MD, PhD


Affiliations: From the Department of Psychiatry, Schulich School of Medicine & Dentistry, University of Western Ontario London, Ont., Canada (Sabesan, Palaniyappan); and the Robarts Research Institute & Lawson Health Research Institute, London, Ont., Canada (Palaniyappan).

Funding: L. Palaniyappan’s work is supported by the Canadian Institute of Health Research (Foundation Grant 375104), Bucke Family Fund and the Tanna Schulich Endowment Chair.

Competing interests: L. Palaniyappan reports personal fees from Janssen Canada, Otsuka Canada, SPMM Course Limited, UK, and the Canadian Psychiatric Association; book royalties from Oxford University Press; investigator-initiated educational grants from Sunovion, Janssen Canada, and Otsuka Canada; and travel support from Boehringer Ingelheim and Magstim Limited, outside the submitted work. He is a member of the JPN editorial board, but was not involved in the review or the decision to accept this manuscript for publication. P. Sabesan has received speaker fees from Lundbeck Canada.

DOI: 10.1503/jpn.200059